Risk factors
Globus Medical (GMED) risk factors
Item 1A of every Globus Medical Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors60 risks3 new25 dropped18 reworded
Globus added risks concerning FDA medical device approvals, human tissue supply limitations for biologics, and product liability exposure. Tariff risks were updated following the Supreme Court ruling striking down certain 2025 import tariffs. Integration risk disclosures expanded to include both the NuVasive and Nevro mergers.
Filed Feb 24, 2026 - FY2024 10-K risk factors82 risks
Globus Medical relies heavily on the success of its NuVasive integration, surgeon adoption, and key executives like David C. Paul.
Filed Feb 20, 2025